These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30017721)

  • 1. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer.
    Wei W; Luo C; Yang J; Sun B; Zhao D; Liu Y; Wang Y; Yang W; Kan Q; Sun J; He Z
    J Control Release; 2018 Sep; 285():187-199. PubMed ID: 30017721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.
    Pes L; Koester SD; Magnusson JP; Chercheja S; Medda F; Abu Ajaj K; Rognan D; Daum S; Nollmann FI; Garcia Fernandez J; Perez Galan P; Walter HK; Warnecke A; Kratz F
    J Control Release; 2019 Feb; 296():81-92. PubMed ID: 30639692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy.
    Zhang S; Guan J; Sun M; Zhang D; Zhang H; Sun B; Guo W; Lin B; Wang Y; He Z; Luo C; Sun J
    Drug Deliv; 2017 Nov; 24(1):1460-1469. PubMed ID: 28950729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulating a single thioether-bridged oleate prodrug into a self-nanoemulsifying drug delivery system to facilitate oral absorption of docetaxel.
    Cui W; Zhang S; Zhao H; Luo C; Sun B; Li Z; Sun M; Ye Q; Sun J; He Z
    Biomater Sci; 2019 Feb; 7(3):1117-1131. PubMed ID: 30638237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
    Li Y; Chen X; Ji J; Li L; Zhai G
    Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy.
    Yang J; Lv Q; Wei W; Yang Z; Dong J; Zhang R; Kan Q; He Z; Xu Y
    Drug Deliv; 2018 Nov; 25(1):807-814. PubMed ID: 29553858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Engineering Docetaxel Prodrug Nanoassemblies: Response Modules Guiding Efficacy Enhancement and Toxicity Reduction.
    Wang D; Li L; Xu H; Sun Y; Li W; Liu T; Li Y; Shi X; He Z; Zhai Y; Sun B; Sun J
    Nano Lett; 2023 Apr; 23(8):3549-3557. PubMed ID: 37053460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
    Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
    Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
    Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
    Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
    Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery.
    Wei W; He Z; Yang J; Sun M; Sun J
    Drug Deliv Transl Res; 2018 Oct; 8(5):1162-1170. PubMed ID: 29748833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Tumor-Targeting Cathepsin B-Sensitive Gemcitabine Prodrug Covalently Targets Albumin in Situ and Improves Cancer Therapy.
    Zhang H; Sun Z; Wang K; Li N; Chen H; Tan X; Li L; He Z; Sun J
    Bioconjug Chem; 2018 Jun; 29(6):1852-1858. PubMed ID: 29775284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striking a Balance between Carbonate/Carbamate Linkage Bond- and Reduction-Sensitive Disulfide Bond-Bearing Linker for Tailored Controlled Release: In Situ Covalent-Albumin-Binding Gemcitabine Prodrugs Promote Bioavailability and Tumor Accumulation.
    Zhang H; Wang K; Na K; Li D; Li Z; Zhao D; Zhong L; Wang M; Kou L; Luo C; Zhang H; Kan Q; Ding H; He Z; Sun J
    J Med Chem; 2018 Jun; 61(11):4904-4917. PubMed ID: 29768008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity.
    Zhao D; Zhang H; Tao W; Wei W; Sun J; He Z
    Biomater Sci; 2017 Feb; 5(3):502-510. PubMed ID: 28116362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically-engineered protein prodrug-like nanoconjugates for tumor-targeting biomimetic delivery via a SHEATH strategy.
    Chang Y; Yao S; Chen Y; Huang J; Wu A; Zhang M; Xu F; Li F; Huang Y
    Nanoscale; 2019 Jan; 11(2):611-621. PubMed ID: 30556550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy.
    Wang W; Zhang X; Li Z; Pan D; Zhu H; Gu Z; Chen J; Zhang H; Gong Q; Luo K
    Carbohydr Polym; 2021 Sep; 267():118160. PubMed ID: 34119134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy.
    Lu S; Xia R; Wang J; Pei Q; Xie Z; Jing X
    ACS Appl Mater Interfaces; 2021 Oct; 13(39):46291-46302. PubMed ID: 34558902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.
    Zhang Y; Zhang H; Wang J; Liu C; Xing H; Jiang Y; Li X
    Mol Pharm; 2023 May; 20(5):2513-2526. PubMed ID: 37071030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.